The role of complement receptor type 3 (CR3) in nonopsonic recognition of group B streptococci (GBS) by macrophages was investigated. Monoclonal anti-CR3 (anti-Mac-i) inhibited phagocytosis of GBS strains by as much as 50% in serum-free cultures of both mouse peritoneal macrophages and the macrophage cell line PU5-1.8. GBS uptake was unaffected by the presence of anti-C3 or salicylhydroxamate, an inhibitor of the covalent binding reaction of C3. Soluble antibodies to LFA-1 or to the common beta-chain (CD18) of the LFA-1/CR3/p150,95 family of cell adhesion molecules did not inhibit GBS uptake. Down-modulation of surface Mac-1 on macrophages following adherence to anti-Mac-i-or anti-CD18-coated surfaces also inhibited uptake of GBS. Further evidence for GBS interaction with CR3 was demonstrated by reduction of EC3bi rosette formation in macrophages adherent to GBS-coated plates. These studies suggest that GBS can interact with macrophage CR3, promoting phagocytosis in a C3-independent fashion. In the absence of specific immunity in neonates, this recognition mechanism may be a significant virulence determinant for GBS which poorly activate the alternate complement pathway.
-3). Binding of such ligands to the phagocyte CR3 is inhibited by antibodies to the alpha chain of CR3 directed at the C3bi site (recognizes Arg-Gly-Asp or similar sequences [38, 46] ), antibodies directed to lectinlike sites (35, 36) , or antibodies to the leukocyte adhesion molecule common beta chain (37) . Thus, CR3 is implicated to possess multiple sites through which inflammatory microbes may bind, either directly or via fixed C3, and activate phagocyte functions (11, 35) . Complement receptor type four (CR4 [p150,95]) may also possess similar ligand-binding sites (9, 28, 45) .
Group B streptococci (GBS) are major etiological agents of neonatal meningitis and septicemia (18) . In the absence of specific antibody and with limited complement-mediated opsonization of GBS in neonates (16, 18) , susceptibility of GBS to intrinsic opsonin-independent phagocytosis becomes an important virulence determinant. Antibody-and complement-independent uptake of type I, II, and III GBS has been described in both human neutrophils and mouse macrophages (2, 6, 24, 44) . GBS also interact with cultured macrophages in the absence of antibody opsonins to stimulate enhanced C3 synthesis (20) . The 44195-5038. nonopsonic recognition between GBS and phagocytes is largely unknown.
Experiments described here examine the role of CR3 in antibody-and complement-independent interactions of GBS with cultured macrophages. Monoclonal anti-CR3 (antiMac-1) was found to inhibit GBS uptake by macrophages. Phagocytosis of GBS strains by mouse macrophages and macrophage cell lines in serum-free cultures was found to be CR3 dependent but C3 independent.
MATERIALS AND METHODS
Macrophages. The mouse macrophagelike cell line, PU5-1.8 (monocytic tumor, BALB/c [31] ), was obtained from the American Type Culture Collection (Rockville, Md.). PU5-1.8 cells were maintained in Dulbecco modified Eagle medium with 4,500 mg of glucose (GIBCO) per liter supplemented with 10% (vol/vol) fetal bovine serum (Hyclone Laboratories, Inc., Logan, Utah) and antibiotic-antimycotic (GIBCO) in a humidified atmosphere with 5% CO2 at 37°C. When grown to confluence, these cells were subcultured by gentle agitation and dilution into fresh medium.
Resident peritoneal macrophages were obtained by peritoneal lavage of C02-asphyxiated BALB/c mice (male or female, bred in-house or purchased from Charles Rivers Laboratories) with 3 to 5 ml of cold Dulbecco calcium-and magnesium-free phosphate-buffered saline (PBS) plus 2 mg of glucose per ml. Macrophage numbers were determined based on total and differential cell counts of peritoneal cells. Macropha es were purified by adherence to 96-well culture plates (10 macrophages per well) or chamber slides (LabTek; Nunc, Inc.; 2 x 105 macrophages per well) for 90 to 120 min; this was followed by washing to remove nonadherent cells. antibodies. The cell monolayers masked most of the background binding of the secondary antibody to the coated antibodies so that this method could distinguish the coated antibody from the staining antibody. EC3bi. EC3bi (erythrocyte-antibody complement complexes) used to detect functional CR3 on macrophages were prepared by the sequential addition of anti-sheep erythrocytes (IgM) and complement (C5-deficient mouse serum) to sheep erythrocytes (34) . EC3bi preparations were free of Role of Mac-1 in phagocytosis of GBS. Mouse macrophage phagocytosis of GBS was inhibited by 30 to 50% by treatment of adherent macrophages with anti-Mac-1, while it was not significantly inhibited by treatment with anti-LFA-1 or by treatment with anti-CD18 ( Table 2) . Results were similar whether measuring uptake by fluorescence microscopy or by microscopic examination of fixed and stained cells. Summarizing data from several experiments, anti-Mac-1 inhibited phagocytosis of GBS 090 by 31% in resident macrophages (49% inhibition when judging phagocytic indices). AntiMac-1 also inhibited phagocytosis of 090 by 44% in thioglycolate-elicited inflammatory macrophages and by 63% in Corynebacterium parvum-activated macrophages (data not shown). Dose-response studies revealed progressive inhibition of phagocytosis with increasing final concentrations of M1/70 conditioned medium or purified anti-Mac-1, but no more than 50 to 60% inhibition of phagocytosis could be achieved at any concentration of anti-Mac-1, but no more than 50 to 60% inhibition of phagocytosis could be achieved at any concentration of anti-Mac-1. Purified anti-Mac-1 (1 to 10 ,ug/ml) also inhibited phagocytosis in PU5-1.8 cells maximally to approximately 50% of controls. Anti-Mac-1 did not cause a general inhibition of phagocytosis as shown by uninhibited uptake of latex beads [104% + 22% (n = 3) and 94% + 10% (n = 2) of untreated control-level phagocytosis for PU5-1.8 and resident peritoneal macrophages, respectively]. Anti-Mac-I effects were dependent on treating the macrophages since pulse treatment of bacteria with anti- with heat-inactivated serum. Unopsonized GBS and GBS incubated with salicylhydroxamate-treated mouse serum were engulfed equally by PU5-1.8 cells. Anti-Mac-1 treatment of macrophages reduced phagocytosis of unopsonized and serum-opsonized GBS to the same final levels, indicating that phagocytosis of GBS, unopsonized or complement opsonized, is mediated via CR3. Phagocytosis of GBS by macrophages depleted of CR3 by adherence to anti-Mac-i. Specific down-modulation of surface Mac-1 has been reported to occur on macrophages adherent to specific antibody-coated surfaces (47). PU5-1.8 cells and resident mouse macrophages were thus adhered to anti-Mac-i-coated surfaces and compared with macrophages adherent to uncoated surfaces for phagocytosis of GBS. Macrophages adherent to anti-Mac-l-coated surfaces exhibited relatively specific down-modulation of surface Mac-1 antigen to less than 50% of control levels in PU5-1.8 and resident macrophages (Tables 5 and 6 ). Incomplete modula- (Table 6) showed statistically significant reductions of both apical Mac-1 levels and phagocytic index. The disparity between anti-CD18 effects on phagocytic index versus percent phagocytosis (Table 6 ) is unexplained; however, in almost all cases in which phagocytosis was reduced by either anti-Mac-1 or anti-CD18, phagocytic index was reduced much more than percent phagocytosis. It may be that modulated Mac-1 has a reduced efficiency of GBS interactions (phagocytic index) but that modulated Mac-1 retains phagocytic function (percent phagocytosis) unless the specific GBS-binding site is blocked. In PU5-1.8 cells (Table 5) , in which anti-CD18 did not cause a significant down-modulation of CR3, phagocytosis was not significantly reduced. Resident peritoneal macrophages adherent to anti-Mac-3 exhibited an interesting increase in surface Mac-1 with a corresponding significant increase in both percent phagocytosis and phagocytic index for GBS (Table 6 ). Phagocytosis of latex beads was slightly (Table 7) .
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DISCUSSION
These studies suggest that antibody and complementindependent phagocytosis of GBS is mediated in part by macrophage CR3 as shown by inhibition with anti-Mac-1. Macrophages adhering to anti-Mac-i-or anti-CD18-coated surfaces had diminished phagocytosis of GBS, and macrophages adhering to GBS-coated surfaces had diminished CR3 function (EC3bi rosettes). A direct recognition event between GBS and CR3 is indicated. Prior to development of specific anti-GBS immunity in newborns infected with GBS, this recognition mechanism may be a significant event in defense against GBS which do not activate the alternate complement pathway.
The importance of leukocyte adhesion molecules (LFA-1, CR3, p150,95) in all aspects of leukocyte function (adherence, migration, particle recognition, phagocytosis, cellular activation) has been revealed in recent years (reviewed in reference 3). This family of molecules can serve as receptors to mediate opsonin-dependent and opsonin-independent binding and phagocytosis of many diverse microorganisms (27, 32, 37, 45) . A rare inherited deficiency of leukocyte adhesion molecules, leucocyte adhesion deficiency disease (LAD or Leu-CAM deficiency), results in recurrent and often fatal bacterial infections (3) . Observations of impaired leucocyte adhesion molecule levels (8, 19) or function (1) and a beta-glucan-binding site on CR3 (35) . Studies by Ross et al. (35) in human granulocytes also suggest that particle (zymosan) binding to CR3 can occur at both C3-dependent and C3-independent sites on its distinct alpha chain. Wright et al. (46) have also described two classes of ligands for CR3. C3bi, fibrinogen, and Leishmania gp63 possess the RGD (Arg-Gly-Asp) site or related site (38, 43, 46) (37) and particle-bound lipophosphoglycan (43 (48) . Since GBS are ingested by resident peritoneal macrophages, this indicates that GBS are interacting with a site, other than the C3bi site, which triggers ingestion.
Insufficient comparisons of phagocytic indices for GBS strains and serotypes were conducted to determine whether the bacterial ligand for CR3 is a uniform characteristic; however, Smith et al. (41) report a differential inhibition of type Ia versus type III GBS opsonophagocytosis by antibodies to CR3. The chemical nature of the GBS ligand for CR3 is unknown, but GBS polysaccharides may be recognized by the reported lectinlike activity of CR3 (10, 35, 41) . The use of heat-killed GBS in this study may introduce artificial phagocytic responses; however, phagocyte bactericidal studies (data not shown) with living GBS show dependence on similar nonopsonic mechanisms. Smith et al. (41) found a similar CR3 dependence for opsonophagocytosis of living GBS by human neutrophils. Inhibition or activation of phagocyte functions following binding of CR3 by the GBS ligand are likely to play a role in both infectious outcome and GBS-induced inflammation (42) .
GBS virulence correlates with elevated secretion of type antigens (13, 25) and resistance to phagocytosis in the absence of specific opsonins (2, 15, 44) . GBS virulence is partially related to poor opsonophagocytosis via the alternate complement pathway (16) ; therefore, relative nonopsonic uptake may be a virulence determinant of GBS strains and recognition via adhesion molecules may be an important early nonspecific defense. Since immunity to GBS rests primarily on effective phagocytosis promoted by polysaccharide type-specific antibodies and complement (4, 16) , the significance of opsonin-independent CR3-mediated uptake must be determined by virulence studies of GBS versus CR3 interactions. The interaction of GBS with CR3 may be a key triggering event in both opsonin-dependent and opsoninindependent phagocytosis.
The basis for the susceptibility of neonates versus the resistance of adults to GBS infection still remains an area for speculation and investigation. The predominant hypotheses for neonatal susceptibility to GBS are based on evidence of (i) decreased complement levels and function in neonates versus adults (reviewed in reference 14) or (ii) impaired phagocyte migration and impaired phagocytosis or killing in neonates versus adults (6, 22, 26, 30, 39) . Fleit (19) reported that similar percentages of adult versus cord blood polymorphonuclear phagocytes express FcR-yIII, CR1, and CR3. Fleit (19) (41) found that combined antibody blockade of both CR1 and the lectinlike site of CR3 significantly reduced killing of GBS by neonatal phagocytes. Whereas phagocytosis of many bacteria is similar in neonatal versus adult phagocytes (26) , reduced levels or function of CR3 in neonatal versus adult phagocytes might explain the differential susceptibility of neonates to bacteria whose uptake is CR3 dependent.
